No immediate trading implications. Monitor future Form 4 filings for any actual insider buying or selling activity by Gall or other executives.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 27 $26.33entry
- T+1 · 7mo ago −4.52%α −4.03% · $25.14
- T+5 · 7mo ago −13.75%α −14.15% · $22.71
- T+20 · 6mo ago −23.89%α −28.85% · $20.04
- T+60 · 4mo ago +6.72%α +1.95% · $28.10
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Matthew Gall, CFO of Tango Therapeutics, filed a Form 3 and granted a power of attorney to Julie Fogarty to file SEC reports on his behalf, including Forms 3, 4, and 5. This is a routine compliance filing related to insider reporting obligations.
Key Facts
- Matthew Gall, CFO of Tango Therapeutics, filed a Form 3 indicating initial beneficial ownership reporting.
- He granted power of attorney to Julie Fogarty to file Forms 3, 4, and 5, Schedule 13D/G, and amendments on his behalf.
- The filing was made effective as of April 24, 2026, with a report date of April 15, 2026.
- No transaction or change in beneficial ownership was disclosed; this is an administrative filing.
Financial Impact
No financial impact, this is a procedural filing with no disclosed share transactions or ownership changes.
Risk Factors
- None identified, this is a standard regulatory requirement for officers and directors.
- Potential for misinterpretation as a signal, but no material information was conveyed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-177281 |
| Document: 0001193125-26-177281-index-headers.html | 0001193125-26-177281 |
| Document: 0001193125-26-177281-index.html | 0001193125-26-177281 |
| Document: 0001193125-26-177281.txt | 0001193125-26-177281 |
Track record
27 reports on TNGX
3 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +29.28% at T+60 after the Jun 8, 2026 report. 5 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.22 Now $24.17 +0.21% settles Feb 16
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.50 Now $24.17 +1.35% settles Feb 12
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $22.74 Now $24.17 +6.29% settles Feb 5
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $21.50 Now $24.17 +12.42% settles Feb 4
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $20.87 Now $24.17 +15.81% settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $23.34 Now $24.17 +3.56% settles Jan 21
- Aug 11, 202613w ago 8-K Bearish 6/10 Entry $25.58 to $23.18 Now $24.17 +5.51% ▲ +9.38% +4.51% vs SPY
- Aug 11, 202613w ago 8-K Bullish 7/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers